Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Suzuken Co ( (JP:9987) ).
Suzuken has provided an update on its ongoing share repurchase program, disclosing that it bought back 375,900 common shares in February 2026 for a total of approximately 2.41 billion yen through market purchases on the Tokyo Stock Exchange. This activity is part of a broader buyback authorization running from May 2025 to March 2026, under which the company aims to repurchase up to 5.2 million shares or 26 billion yen.
As of February 27, 2026, Suzuken has repurchased a cumulative 4,354,700 shares for about 25.33 billion yen, nearly reaching the approved monetary ceiling for the program. The near-completion of the buyback framework signals a strong capital allocation stance and may support shareholder value by reducing the free float and potentially enhancing earnings per share, while underscoring management’s confidence in the company’s financial position.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen7068.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. is a Japanese company listed on the Prime Market of the Tokyo and Nagoya Stock Exchanges, as well as the Sapporo Securities Exchange. The company operates in the healthcare and pharmaceutical distribution sector, focusing on supplying medicines and related products across Japan.
YTD Price Performance: 7.75%
Average Trading Volume: 169,398
Technical Sentiment Signal: Buy
Current Market Cap: Yen375B
For detailed information about 9987 stock, go to TipRanks’ Stock Analysis page.